Screening for strongyloidiasis in Spain in the context of the SARS-CoV-2 pandemic: Results of a survey on diagnosis and treatment

INTRODUCTION: The generalization of treatment with dexamethasone or other immunosuppressants in patients with SARS-CoV-2 infection may increase the risk of occurrence of severe forms of strongyloidiasis. A nationwide survey was conducted to better understand the diagnostic and therapeutic situation...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez-Guardado, Azucena, Álvarez-Martínez, Miriam J., Flores, María Delmans, Sulleiro, Elena, Torrús-Tendero, Diego, Velasco, María, Membrillo, Francisco Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier España, S.L.U. on behalf of Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372776/
https://www.ncbi.nlm.nih.gov/pubmed/35970704
http://dx.doi.org/10.1016/j.eimce.2022.08.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372776/
https://www.ncbi.nlm.nih.gov/pubmed/35970704
http://dx.doi.org/10.1016/j.eimce.2022.08.006

Ejemplares similares